
The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices. That’s one of several priorities federal officials detailed June 10 in JAMA. They said AI could help shorten review times, speeding delivery of treatments to people who need them. … read on > read on >